{"schema_version":"secwatch.filing_event.v1","accession":"0001906324-24-000042","form_type":"8-K","ticker":"QDEL","cik":"0001906324","company_name":"QuidelOrtho Corp","filed_at":"2024-07-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.173858+00:00","generated_at":"2026-05-31T14:31:57.338542+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"QuidelOrtho Q2 2024: revenue $637M, GAAP diluted loss ($2.20)/share","bullets":["Total revenue $637M, down 4% YoY; lower COVID-19 revenue was primary driver.","GAAP diluted loss per share ($2.20) vs ($0.80) prior year; GAAP operating loss ($118M).","Adjusted diluted loss per share ($0.07) vs +$0.26; adjusted EBITDA $90M (14% margin).","Announced $100M annualized cost-savings initiatives to benefit H2 2024 and H1 2025.","Ex-COVID & U.S. Donor Screening, recurring revenue grew 5% constant currency YoY."],"urls":{"canonical":"https://secwatch.observer/filing/0001906324-24-000042","json":"https://secwatch.observer/filing/0001906324-24-000042.json","markdown":"https://secwatch.observer/filing/0001906324-24-000042.md","text":"https://secwatch.observer/filing/0001906324-24-000042.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1906324/000190632424000042/0001906324-24-000042-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1906324/000190632424000042/qdel-20240731.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T14:31:57.338542+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}